financetom
Business
financetom
/
Business
/
Loblaw's quarterly results beat estimates on grocery, pharmacy demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Loblaw's quarterly results beat estimates on grocery, pharmacy demand
May 25, 2025 9:50 PM

(Reuters) -Canadian retailer Loblaw exceeded analysts' expectations for first-quarter revenue and profit on Wednesday, driven by robust demand at its pharmacy stores and discount banners, Maxi and No Frills, for everyday essentials.

Consumers in Canada have become more wary with their spending as U.S. President Donald Trump's tariffs have increased worries about rising inflation that could further tighten household budgets.

Canada's retail sales shrank faster than anticipated in January. The country's central bank has forecast that consumer spending will drop and GDP will be hit as Canadian businesses and consumers deal with a wave of tariffs from the Trump administration.

This has pushed people to look for lower-priced items, boosting demand at Loblaw's discount banners which offer everything from fruits to household items.

The Canadian supermarket chain also enjoyed strong demand for cosmetics and saw growth in pharmacy sales due to an extended cold and flu season, which helped offset an exit from certain low-margin electronic products.

Same-store sales at the company's food retail segment rose 2.2% in the first quarter, while comparable sales at its drug retail unit increased 3.8%.

Loblaw still continues to see tight spending on discretionary items such as home appliances and furniture, which analysts have said would take long to recover.

The company's revenue rose 4.1% to C$14.14 billion ($10.22 billion) in the first quarter, compared with the average analyst estimate of C$14.07 billion, according to data compiled by LSEG.

On an adjusted basis, Loblaw earned C$1.88 per share, topping expectations of C$1.87.

The company reaffirmed its annual adjusted net earnings per share forecast of high single-digit percentage growth.

($1 = 1.3829 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chevron to cut nearly 800 jobs in Texas
Chevron to cut nearly 800 jobs in Texas
May 28, 2025
HOUSTON (Reuters) -Chevron ( CVX ) will lay off nearly 800 employees in Texas, according to a notice on Wednesday to the Texas Workforce Commission, part of the U.S. oil producer's plan to cut up to 20% of its global workforce by the end of 2026. The job cuts will be in Midland County, where Chevron ( CVX ) has...
Chevron to cut nearly 800 jobs in Texas
Chevron to cut nearly 800 jobs in Texas
May 28, 2025
HOUSTON, May 28 (Reuters) - Chevron ( CVX ) will lay off nearly 800 employees in Texas, according to a notice on Wednesday to the Texas Workforce Commission, part of the U.S. oil producer's plan to cut up to 20% of its global workforce by the end of 2026. The job cuts will be in Midland County, where Chevron (...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
US cancels more than $700 million funding for Moderna bird flu vaccine
US cancels more than $700 million funding for Moderna bird flu vaccine
May 28, 2025
(Reuters) -The Trump administration has canceled a contract awarded to Moderna ( MRNA ) for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced on Wednesday. Shares of Moderna ( MRNA ) were flat in after-market trading. Moderna ( MRNA ) in January was awarded $590 million by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved